ACAP Webinar: Thursday, July 24th | 2:00PM EST

July 9, 2025

medicaid

As GLP-1 medications like Ozempic, Wegovy and Zepbound surge in popularity for treating diabetes and obesity, Medicaid programs across the U.S. are grappling with unprecedented financial and policy challenges.  With patients paying upwards of $11,000 annually for a year supply, and Medicaid spending on these drugs skyrocketing from $577 million in 2019 to nearly $4 billion in 2023, health plans are under immense pressure to balance access, equity and sustainability.

Join Evernorth’s panel of experts from Express Scripts Pharmacy Benefit Services for a discussion on key topics including GLP-1 utilization trends, state-by-state insights, ROI and value assessment and formulary management strategies. REGISTER NOW!

Initiatives

Calls grow for Drug Patent reform

In a recent blog post, the Pharmaceutical Care Management Association (PCMA) highlighted increased attention to pharmaceutical companies’ abuse of drug patents. Last month, the Supreme Court unanimously ruled in favor of a generic drugmaker in a “skinny labeling” case, a victory for patients. Skinny labels allow generic and biosimilar competitors to launch products for non-patented indications, helping accelerate […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

perspectives

AHIP calls for Bipartisan reform to address health care cost drivers

On July 23, AHIP President and CEO Mike Tuffin wrote an opinion piece in The New York Times saying, “common-sense bipartisan reforms are needed to promote competition in care delivery and prescription drugs, protect consumers from providers and drugmakers’ anticompetitive practices and transition away from the perverse incentives of fee-for-service medicine.” Tuffin notes that health […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

Solutions

PCMA urges preserving patient access and flexibility in new fertility benefits rule

PCMA recently submitted comments to HHS, DOL, and the Treasury (the Departments) in response to the proposed rule establishing a new category of limited excepted benefits for fertility services. PCMA supports the Departments’ goal of expanding access to fertility care while encouraging employer innovation but urged several targeted refinements to ensure the framework is operationally […]
read more >

August 11, 2026

marketplace medicaid

You may also like